Ecto-nucleotidases, molecular properties and functional impact

Anales de la Real Academia Nacional de Farmacia

Volumn 73, Issue 2, 2007, Pages 537-566

  Zimmermann, Herbert ^a   Mishra, Santosh K ^a   Shukla, Varsha ^a   Langer, David ^a   Gampe, Kristine ^a   Grimm, Ivette ^a   Delic, Jasmin ^a   Braun, Norbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

5 nucleotidase; Alkaline phosphatase; ATP; Ecto ATPase; Neurogenesis

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; ECTO 5' NUCLEOTIDASE; NUCLEOTIDASE; NUCLEOTIDE DERIVATIVE;

ENZYME ACTIVITY; ENZYME LOCALIZATION; MOLECULAR BIOLOGY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE METABOLISM; REVIEW; TISSUE DISTRIBUTION;

EID: 35548942342     PISSN: None     EISSN: 1697428X     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. BURNSTOCK, G. and KNIGHT, G. E. (2004): Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240: 31-304.
2. BURNSTOCK, G. (1972): Purinergic nerves. Pharmacol. Rev. 24: 509-581.
3. BURNSTOCK, G. (1998): History of extracellular nucleotides and their receptors. in: The P2 Nucleotide Receptors (Turner J. T., Weisman G. A. and Fedan J. S., Eds), pp. 3-40. Humana Press, Totowa, New Jersey.
4. 11 purinergic receptor in human granulocytes. J. Biol. Chem. 281: 31419-31429.
5. SCHWIEBERT, E. M.; ZSEMBERY, A. and GEIBEL, J. P. (2003): Cellular mechanisms and physiology of nucleotide and nucleoside release from cells: Current knowledge, novel assays to detect purinergic agonists, and future directions. in: Extracellular Nucleotides and Nucleosides: Release, Receptors, and Physiological and Pathophysiological Effects (Schwiebert, E. M, Ed), pp. 31-58. Academic Press, Amsterdam, New York, Tokyo.
6. King, A. E.; Ackley, M. A.; Cass, C. E.; Young, J. D. and Baldwin, S. A. (2006): Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharm. Sci. 27: 416-425.
7. HOYLE, C. H. V.; HILDERMAN, R. H.; PINTOR, J. J.; SCHLÜTER, H. and KING, B. F. (2001): Diadenosine polyphosphates as extracellular signal molecules. Drug Develop. Res. 52: 260-273.
8. DELICADO, E. G.; MIRAS-PORTUGAL, M. T.; CARRASQUERO, L. M. G.; LEON, D.; PÉREZ- SEN, R. and GUALIX, J. (2006): Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways. Pflugers Arch. Eur. J. Physiol. 452: 563-572.
9. MARUYAMA, K. (1991): The discovery of adenosine triphosphate and the establishment of its structure. J. Hist. Biol. 24: 145-154.
10. DRURY, A. N. and SZENT-GYÖRGYI, A. (1929): The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol-London 68: 213-237.
11. GILLESPIE, J. H. (1934): The biological significance of the linkages in adenosine triphosphoric acid. J. Physiol. London. 80: 345-359.
12. FANTL, P. and WARD, H. A. (1956): Nucleotides in human platelets. Biochem. J. 64: 747-754.
13. DA PRADA, M.; PLETCHER, A.; TRANZER, J. P. and KNUCHEL, H. (1967): Subcellular localization of 5-hydroxytryptamine and histamine in blood platelets. Nature. 216: 315-317.
14. FALCK, B.; HILLARP, N.-Å. and HÖGBERG, B. (1956): Content and intracellular distribution of adenosine triphosphate in cow adrenal medulla. Acta Phys. Scand. 36: 360-376.
15. BLASCHKO, H.; BORN, G. V. R.; D'IORIO, A. and EADE, N. R. (1956): Observations on the distribution of catecholamines and adenosine triphosphate in the bovine adrenal medulla. J. Physol. Lond. 133: 548-557.
16. SCHÜMANN, H. J. (1968): Noradrenalin and ATP content of sympathetic nerves. Naunyn-Schmiedeberg's Arch. Pharmacol. 233: 296-300.
17. DOWDALL, M. J.; BOYNE, A. F. and WHITTAKER, V. P. (1974): Adenosine triphosphate, a constituent of cholinergic synaptic vesicles. Biochem. J. 140: 1-12.
18. ZIMMERMANN, H. (1994): Signalling via ATP in the nervous system. Trends Neurosci. 17: 420-426.
19. ZIMMERMANN, H. and WHITTAKER, V. P. (1974): The effect of electrical stimulation on the yield and composition of synaptic vesicles from the cholinergic synapses of the electric organ of Torpedo: A combined biochemical, electrophysiological and morphological study. J. Neurochem. 22: 435-450.
20. ZIMMERMANN, H. (1982): Coexistence of adenosine 5′-triphosphate and acetylcholine in the electromotor synapse. In: Co-Transmission (Cuello A. C. Ed), pp. 243-259. The MacMillan Press, London.
21. MANN, T. (1945): Studies on the metabolism of semen 1. General aspects. Occurrence and distribution of cytochrome, certain enzymes and coenzymes. Biochem. J. 39: 451-458.
22. ROHSTEIN, A. and MEIER, R. (1948): The relationship of the cell surface to metabolism. I. Phosphatases in the cell surface of living yeast cells. J. Cell. Comp. Physiol. 32: 77-95.
23. CLARKSON, E. M. and MAIZELS, M. (1952): Distribution of phosphatase in human erythrocytes. J. Physiol. London. 116: 112-128.
24. ACS, G.; OSTROWSKI, W. and STRAUB, F. B. (1954): [Adenylpyrophosphatase activity on the surface of ascites tumor cells]. Acta Physiol. Hung. 6: 261-263.
25. ENGELHARDT, W. A. (1958): Enzymes as structural elements of physiological mechanisms. I. U. B. Symposium Series. 2: 163-168.
26. WENKSTERN, T. W. and ENGELHARDT, W. A. (1959): [The adenosine polyphosphatase localized on the surface of nucleated red corpuscles]. Folia Haematol. Int. Mag. Klin. Morphol. Blutforsch. 76: 422-431.
27. ABOOD, L. G. and GERARD, R. W. (1954): Enzyme distribution in isolated particles of rat peripheral nerve. J. Cell Physiol. 43: 379-392.
28. WACHSTEIN, M. and MEISEL, E. (1957): Histochemistry of hepatic phosphatases at a physiologic pH with special reference to the demonstration of bile canaliculi. Am. J. Clin. Pathol. 13-23.
29. ESSNER, E.; NOVIKOFF, A. B. and MASEK, B. (1958): Adenosine triphosphatase and 5′-nucleotidase activities in the plasma membrane of liver cells as revealed by electron microscopy. J. Biophys. Biochem. Cytol. 4: 711-716.
30. KAM, W.; CLAUSER, E. M.; KIM, Y. S.; KAN, Y. W. and RUTTER, W. J. (1985): Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc. Natl. Acad. Sci. USA. 82: 8715-8719.
31. VAN DRIEL, I. R.; WILKS, A. F.; PIETERSZ, G. A. and GODING, J. W. (1985): Murine plasma cell membrane antigen PC-1: Molecular cloning of cDNA and analysis of expression. Proc. Natl. Acad. Sci. USA. 82: 8619-8623.
32. MISUMI, Y.; OGATA, S.; HIROSE, S. and IKEHARA, Y. (1990): Primary structure of rat liver 5′- nucleotidase deduced from the cDNA. Presence of the COOH-terminal hydrophobic domain for possible post-translational modification by glycophospholipid. J. Biol. Chem. 265: 2178-2183.
33. MAENHAUT, C.; VAN SANDE, J.; LIBERT, F.; ABRAMOWICZ, M.; PARMENTIER, M.; VANDERHAEGEN, J. J.; DUMONT, J. E.; VASSART, G. and SCHIFFMANN, S. (1990): RDC8 codes for an adenosine receptor with physiological constitutive activity. Biochem. Biophys. Res. Commun. 173: 1169-1178.
34. LUSTIG, K. D.; SHIAU, A. K.; BRAKE, A. J. and JULIUS, D. (1993): Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA. 90: 5113-5117.
35. WEBB, T. E.; SIMON, J.; KRISHEK, B. J.; BATESON, A. N.; SMART, T. G.; KING, B. F.; BURNSTOCK, G. and BARNARD, E. A. (1993): Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324: 219-225.
36. BRAKE, A. J.; WAGENBACH, M. J. and JULIUS, D. (1994): New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371: 519-523.
37. VALERA, S.; HUSSY, R. J.; EVANS, N.; ADAMI, R.; NORTH, R. A.; SURPRENANT, A. and BUELL, G. (1994): A new class of ligand gated ion channel defined by P2X receptor for extracellular ATP. Nature. 371: 516-519.
38. 2+)-apyrase. J. Biol. Chem. 271: 9898-9901.
39. KACZMAREK, E.; KOZIAK, K.; SÉVIGNY, J.; SIEGEL, J. B.; ANRATHER, J.; BEAUDOIN, A. R.; BACH, F. H. and ROBSON, S. C. (1996): Identification and characterization of CD39 vascular ATP diphosphohydrolase. J. Biol. Chem. 271: 33116-33122.
40. ZIMMERMANN, H. (2001): Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev. Res. 52: 44-56.
41. ROBSON, S. C.; SÉVIGNY, J. and ZIMMERMANN, H. (2006): The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signalling. 2: 409-430.
42. GODING, J. W.; GROBBEN, B. and SLEGERS, H. (2003): Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. BBA. Mol. Basis. Dis. 1638: 1-19.
43. STEFAN, C.; JANSEN, S. and BOLLEN, M. (2006): Modulation of purinergic signaling by NNP-type ectophosphodiesterases. Purinergic Signalling. 2: 361-370.
44. TERKELTAUB, R. (2006): Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing in calcification. Purinergic Signalling. 2: 371-377.
45. MILLAN, J. L. (2006): Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signalling. 2: 335-341.
46. MILLAN, J. L. (2006): Mammalian alkaline phosphatases. From biology to applications in medicine and biotechnology. Wiley-VCH Verlag GmbH & Co, Weinheim, Germany.
47. FREDHOLM, B. B.; ABBRACCHIO, M. P.; BURNSTOCK, G.; DALY, J. W.; HARDEN, T. K.; JACOBSON, K. A.; LEFF, P. and WILLIAMS, M. (1994): Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46: 143-156.
48. ZIMMERMANN, H.; BEAUDOIN, A. R.; BOLLEN, M.; GODING, J. W.; GUIDOTTI, G.; KIRLEY, T. L.; ROBSON, S. C. and SANO, K. (2000): Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface. in: Ecto-ATPases and Related Ectonucleotidases (van Duffel, L., Lemmens, R. Eds), pp. 1-8. Shaker Publishing BV, Maastricht.
49. 1 ATPase: metabolic and immunological functions. Curr. Opin. Lipidol. 17: 279-284.
50. DEAGLIO, S. and MALAVASI, F. (2006): The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leucocyte surface enzymes. Purinergic Signalling. 2: 431-441.
51. ZIMMERMANN, H. (1992): 5′-Nucleotidase - molecular structure and functional aspects. Biochem. J. 285: 345-365.
52. BIANCHI, V. and SPYCHALA, J. (2003): Mammalian 5′-nucleotidases. J. Biol. Chem. 278: 46195-46198.
53. YEGUTKIN, G. G.; HENTTINEN, T.; SAMBURSKI, S. S.; SPYCHALA, J. and JALKANEN, S. (2002): The evidence for two opposite, ATP-generating and ATP- consuming, extracellular pathways on endothelial and lymphoid cells. Biochem. J. 367: 121-128.
54. PICHER, M. and BOUCHER, R. C. (2003): Human airway ecto-adenylate kinase - A mechanism to propagate ATP signaling on airway surfaces. J. Biol. Chem. 278: 11256-11264.
55. BIGONNESSE, F.; LÉVESQUE, S. A.; KUKULSKI, F.; LECKA, J.; ROBSON, S. C.; FERNANDES, M. J. G. and SÉVIGNY, J. (2004): Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry USA. 43: 5511-5519.
56. VORHOFF, T.; ZIMMERMANN, H.; PELLETIER, J.; SÉVIGNY, J. and BRAUN, N. (2005): Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: predicted secondary structure and relation to members of the E-NTPDase family and actin. Purinergic Signalling. 1: 259-270.
57. KIRLEY, T. L.; CRAWFORD, P. A. and SMITH, T. M. (2006): The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses. Purinergic Signalling. 2: 379-389.
58. IVANENKOV, V. V.; MELLER, J. and KIRLEY, T. L. (2005): Characterization of disulfide bonds in human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): Implications for NTPDase structural modeling. Biochemistry USA. 44: 8998-9012.
59. MASSÉ, K.; EASON, R.; BHAMRA, S.; DALE, N. and JONES, E. A. (2006): Comparative genomic and expression analysis of the conserved NTPDase gene family in Xenopus. Genomics. 87: 366-381.
60. ZIMMERMANN, H. (2001): Ecto-nucleotidases. in: Handbook of Experimental Pharmacology. Purinergic and Pyrimidergic Signalling. (Abbracchio, M. P. and Williams, M. Eds), pp. 209-250 Springer Verlag, Heidelberg.
61. BRAUN, N.; SÉVIGNY, J.; ROBSON, S. C.; ENJYOJI, K.; GUCKELBERGER, O.; HAMMER, K.; DI VIRGILIO, F. and ZIMMERMANN, H. (2000): Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur. J. Neurosci. 12: 4357-4366.
62. BRAUN, N. and ZIMMERMANN, H. (2001): Microglial ectonucleotidases: Identification and functional roles. Drug Develop. Res. 53: 208-217.
63. BRAUN, N.; SÉVIGNY, J.; ROBSON, S. C.; HAMMER, K.; HANANI, M. and ZIMMERMANN, H. (2004): Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system. Glia. 45: 124-132.
64. BRAUN, N.; SÉVIGNY, J.; MISHRA, S.; ROBSON, S. C.; BARTH, S. W.; GERSTBERGER, R.; HAMMER, K. and ZIMMERMANN, H. (2003): Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur. J. Neurosci. 17: 1355-1364.
65. SHUKLA, V.; ZIMMERMANN, H.; WANG, L.; KETTENMANN, H.; RAAB, S.; HAMMER, K.; SÉVIGNY, J.; ROBSON, S. C. and BRAUN, N. (2005): Functional expression of the ecto-ATPase NTPDase2 and of nucleotide receptors by neuronal progenitor cells in the adult murine hippocampus. J. Neurosci. Res. 80: 600-610.
66. SMITH, T. M. and KIRLEY, T. L. (1998): Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ectoapyrases. Biochim. Biophys. Acta. 1386: 65-78.
67. LAVOIE, É. G.; KUKULSKI, F.; LÉVESQUE, S. A.; LECKA, J. and SÉVIGNY, J. (2004): Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-3. Biochem. Pharmacol. 67: 1917-1926.
68. KUKULSKI, F.; LÉVESQUE, S. A.; LAVOIE, É. G.; LECKA, J.; BIGONNESSE, F.; KNOWLES, A. F.; ROBSON, S. C.; KIRLEY, T. L. and SÉVIGNY, J. (2005): Comparative hydrolysis of P2 receptor agonists by NTPDase 1, 2, 3 and 8. Purinergic Signalling. 1: 193-204.
69. GIJSBERS, R.; CEULEMANS, H.; STALMANS, W. and BOLLEN, M. (2001): Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J. Biol. Chem. 276: 1361-1368.
70. ZALATAN, J. G.; FENN, T. D.; BRUNGER, A. T. and HERSCHLAG, D. (2006): Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: Implications for mechanism and evolution. Biochemistry USA. 45: 9788-9803.
71. VOLLMAYER, P.; CLAIR, T.; GODING, J. W.; SANO, K.; SERVOS, J. and ZIMMERMANN, H. (2003): Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/ phosphodiesterases. Eur. J. Biochem. 270: 2971-2978.
72. ROTLLÁN, P.; ASENSIO, A. C.; RAMOS, A.; RODRÍGUEZ-FERRER, C. R. and OAKNIN, S. (2002): Ectoenzymatic hydrolysis of the signalling nucleotides diadenosine polyphosphates. Recent Res. Devel. Biochem. 3: 191-209.
73. MIRAS-PORTUGAL, M. T.; GUALIX, J.; MATEO, J.; DÍAZ-HERNÁNDEZ, M.; GÓMEZ-VILLAFUERTES, R.; CASTRO, E. and PINTOR, J. (1999): Diadenosine polyphosphates, extracellular function and catabolism. Prog. Brain Res. 120: 397-409.
74. DENNIS, J.; NOGAROLI, L. and FUSS, B. (2005): Phosphodiesterase-I alpha-/autotaxin (PD-I alpha/ATX): A multifunctional protein involved in central nervous system development and disease. J. Neurosci. Res. 82: 737-742.
75. DE BACKER, M.; MCSWEENEY, S.; RASMUSSEN, H. B.; RUSE, B. W.; LINDLEY, P. and HOUGH, E. (2002): The 1.9 Å crystal structure of heat-labile shrimp alkaline phosphatase. J. Mol. Biol. 318: 1265-1274.
76. YEGUTKIN, G. G.; MIKHAILOV, A.; SAMBURSKI, S. S. and JALKANEN, S. (2006): The detection of micromolar pericellular ATP pool on lymphocyte surface by using lymphoid ecto-adenylate kinase as intrinsic ATP sensor. Mol. Biol. Cell. 17: 3378-3385.
77. SCHULTZ-HEIENBROK, R.; MAIER, T. and STRÄTER, N. (2005): A large hinge bending domain rotation is necessary for the catalytic function of Escherichia coli 5′-nucleotidase. Biochemistry USA. 44: 2244-2252.
78. STRÄTER, N. (2006): Ecto-5′-Nucleotidase: Structure function relationships. Purinergic Signalling. 2: 343-350.
79. CUNHA, R. A. (2001): Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem. Res. 26: 979-991.
80. KOSZALKA, P.; OZUYAMAN, B.; HUO, Y. Q.; ZERNECKE, A.; FLOGEL, U.; BRAUN, N.; BUCHHEISER, A.; DECKING, U. K. M.; SMITH, M. L.; SÉVIGNY, J.; GEAR, A.; WEBER, A. A.; MOLOJAVYI, A.; DING, Z. P.; WEBER, C.; LEY, K.; ZIMMERMANN, H.; GODECKE, A. and SCHRADER, J. (2004): Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95: 814-821.
81. SCHUBER, F. and LUND, F. E. (2004): Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites. Curr. Mol. Med. 4: 249-261.
82. SEMAN, M.; ADRIOUCH, S.; HAAG, F. and KOCH-NOLTE, F. (2004): Ecto-ADP-ribosyltransferases (ARTs): Emerging actors in cell communication and signaling. Curr. Medicinal. Chem. 11: 857-872.
83. 1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2. Mol. Pharmacol. 67: 114-122.
84. MARCUS, A. J.; BROEKMAN, M. J.; DROSOPOULOS, J. H. F.; ISLAM, N.; PINSKY, D. J.; SESTI, C. and LEVI, R. (2003): Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: Implications for ischemic vascular diseases. J. Pharmacol. Exp. Ther. 305: 9-16.
85. SÉVIGNY, J.; SUNDBERG, C.; BRAUN, N.; GUCKELBERGER, O.; CSIZMADIA, E.; QAWI, I.; IMAI, M.; ZIMMERMANN, H. and ROBSON, S. C. (2002): Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) and NTPDase2 have implications for thromboregulation. Blood. 99: 2801-2809.
86. ATKINSON, B.; DWYER, K.; ENJYOJI, K. and ROBSON, S. C. (2006): Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Molec. Dis. 36: 217-222.
87. JHANDIER, M. N.; KRUGLOV, E. A.; LAVOIE, É. G.; SÉVIGNY, J. and DRANOFF, J. A. (2005): Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J. Biol. Chem. 280: 22986-22992.
88. ENJYOJI, K.; SÉVIGNY, J.; LIN, Y.; FRENETTE, P.; CHRISTIE, P. D.; SCHULTE, A. M.; ESCH, J.; IMAI, M.; EDELBERGER, J. M.; RAYBURN, H.; LECH, M.; BEELER, D. M.; CSIZMADIA, E.; WAGNER, D. D.; ROBSON, S. C. and ROSENBERG, R. D. (1999): Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Med. 5: 1010-1017.
89. MIZUMOTO, N.; KUMAMOTO, T.; ROBSON, S. C.; SÉVIGNY, J.; MATSUE, H.; ENJYOJI, K. and TAKASHIMA, A. (2002): CD39 is the dominant Langerhans cell associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness. Nature Med. 8: 358-365.
90. NARISAWA, S.; HUANG, L.; IWASAKI, H.; HASEGAWA, H.; ALPERS, D. H. and MILLAN, J. L. (2003): Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol. Cell. Biol. 23: 7525-7530.
91. NARISAWA, S.; FRÖHLANDER, N. and MILLAN, J. L. (1997): Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia. Develop. Dynam. 208: 432-446.
92. FEDDE, K. N.; BLAIR, L.; SILVERSTEIN, J.; COBURN, S. P.; RYAN, L. M.; WEINSTEIN, R. S.; WAYMIRE, K.; NARISAWA, S.; MILLAN, J. L.; MACGREGOR, G. R. and WHYTE, M. P. (1999): Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14: 2015-2026.
93. HESSLE, L.; JOHNSON, K. A.; ANDERSON, H. C.; NARISAWA, S.; SALI, A.; GODING, J. W.; TERKELTAUB, R. and MILLAN, J. L. (2002): Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA. 99: 9445-9449.
94. ANDERSON, H. C.; HARMEY, D.; CAMACHO, N. P.; GARIMELLA, R.; SIPE, J. B.; TAGUE, S.; BI, X. H.; JOHNSON, K.; TERKELTAUB, R. and MILLÁN, J. L. (2005): Sustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/ nucleotide pyrophosphatase phosphodiesterase 1 double-deficient mice. Amer. J. Pathol. 166: 1711-1720.
95. VAN MEETEREN, L. A.; RUURS, P.; STORTELERS, C.; BOUWMAN, P.; VAN ROOIJEN, M. A.; PRADERE, J. P.; PETTIT, T. R.; WAKELAM, M. J. O.; SAULNIER-BLACHE, J. S.; MUMMERY, C. L.; MOOLENAAR, W. H. and JONKERS, J. (2006): Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol. Cell. Biol. 26: 5015-5022.
96. COLGAN, S. P.; ELTZSCHIG, H. K.; ECKLE, T. and THOMPSON, L. F. (2006): Physiological roles of ecto-5′- nucleotidase. Purinergic Signalling. 2: 351-360.
97. COCKAYNE, D. A.; MUCHAMUEL, T.; GRIMALDI, J. C.; MULLERSTEFFNER, H.; RANDALL, T. D.; LUND, F. E.; MURRAY, R.; SCHUBER, F. and HOWARD, M. C. (1998): Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood. 92: 1324-1333.
98. SUN, L.; IGBAL, J.; DOLGILEVICH, S.; YUEN, T.; WU, X. B.; MOONGA, B. S.; ADEBANJO, O. A.; BEVIS, P. J.; LUND, F.; HUANG, C. L.; BLAIR, H. C.; ABE, E. and ZAIDI, M. (2003): Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-defocoent mouse establishes an essential role for CD38 in bone resorption. FASEB J. 17: 369-375.
99. ITOH, M.; ISHIHARA, K.; HIROI, T.; LEE, B. O.; MAEDA, H.; IIJIMA, H.; YANAGITA, M.; KIYONO, H. and HIRANO, T. (1998): Deletion of bone marrow stromal antigen-1 (CD157) gene impaired systemic thymus independent-2 antigen-induced IgG3 and mucosal TD antigen-elicited IgA responses. J. Immunol. 161: 3974-3983.
100. SALMI, M. and JALKANEN, S. (2005): Cell-surface enzymes in control of leukocyte trafficking. Nature Rev. Immunol. 5: 760-771.
101. BURCH, L. H. and PICHER, M. (2006): E-NTPDases in human airways regulation and relevance for chronic lung diseases. Purinergic Signalling. 2: 399-408.
102. VLAJKOVIC, S. M.; VINAYAGA-MOORTHY, A.; THORNE, P. R.; ROBSON, S. C.; WANG, C. J. H. and HOUSLEY, G. D. (2006): Noise-induced up-regulation of NTPDase3 expression in the rat cochlea: Implications for auditory transmission and cochlear protection. Brain Res. 1104: 55-63.
103. GENDRON, F. P.; BENREZZAK, O.; KRUGH, B. W.; KONG, Q.; WEISMAN, G. A. and BEAUDOIN, A. R. (2002): Purine signaling and potential new therapeutic approach: Possible outcome of NTPDase inhibition. Current Drug Targets. 3: 229-245.
104. KENNEDY, C.; WESTFALL, T. D. and SNEDDON, P. (1996): Modulation of purinergic neurotransmission by ecto-ATPase. Semin. Neurosci. 8: 195-199.
105. WESTFALL, T. D.; KENNEDY, C. and SNEDDON, P. (1997): The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder. Eur. J. Pharmacol. 329: 169-173.
106. DRAKULICH, D. A.; SPELLMON, C. and HEXUM, T. D. (2004): Effect of the ecto-ATPase inhibitor, ARL 67156, on the bovine chromaffin cell response to ATP. Eur. J. Pharmacol. 485: 137-140.
107. GENDRON, F. P.; HALBFINGER, E.; FISCHER, B.; DUVAL, M.; D'ORLÉANS-JUSTE, P. and BEAUDOIN, A. R. (2000): Novel inhibitors of nucleoside triphosphate diphosphohydrolases: Chemical synthesis and biochemical and pharmacological characterizations. J. Med. Chem. 43: 2239-2247.
108. IQBAL, J.; VOLLMAYER, P.; BRAUN, N.; ZIMMERMANN, H. and MÜLLER, C. E. (2005): A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the screening of inhibitors by in-caplllary enzymatic microreactions. Purinergic Signalling. 1: 349-358.
109. MÜLLER, C. E.; IQBAL, J.; BAQI, Y.; ZIMMERMANN, H.; RÖLLICH, A. and STEPHAN, H. (2006) Polyoxometalates - a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Biorog. Med. Chem. Lett. 16: 5943-5947.
110. HEINE, P.; BRAUN, N. and ZIMMERMANN, H. (1999): Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur. J. Biochem. 262: 102-107.
111. HOFFMANN, C.; HEINE, P.; PRADEL, G.; KIM, Y.-C.; JACOBSON, K. A. and ZIMMERMANN, H. (2000): Inhibition of ecto-apyrase and ecto-ATPase by pyridoxal phosphate-related compounds. Drug. Dev. Res. 51, 153-158.
112. MCDOUGALL, K.; PLUMB, C.; KING, W. A. and HAHNEL, A. (2002): Inhibitor profiles of alkaline phosphatases in bovine preattachment embryos and adult tissues. J. Histochem. Cytochem. 50: 415-422.
113. + glycohydrolase activity of CD38 by carbocyclic NAD analogues. Biochem. J. 335: 631-636.
114. FIELDS, R. D. and BURNSTOCK, G. (2006): Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7: 423-436.
115. ZIMMERMANN, H. (2006): Ecto-nucleotidases in the nervous system. Novartis Found. Symp. 275: 113-128.
116. ZIMMERMANN, H. (1996): Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Prog. Neurobiol. 49: 589-618.
117. DUNWIDDIE, T. V.; DIAO, L. H. and PROCTOR, W. R. (1997): Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci. 17: 7673-7682.
118. 1 receptors. J. Neurosci. 18: 1987-1995.
119. 1 receptors. J. Pharmacol. Exp. Ther. 303: 356-363.
120. ARAQUE, A. and PEREA, G. (2004): Glial modulation of synaptic transmission in culture. Glia. 47: 241-248.
121. NEWMAN, E. A. (2004): Glial modulation of synaptic transmission in the retina. Glia. 47: 268-274.
122. FÄRBER, K. and KETTENMANN, H. (2006): Purinergic signaling and microglia. Pflugers Arch. Eur. J. Physiol. 452: 615-621.
123. 4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 424: 778-783.
124. PINSKY, D. J.; BROEKMAN, M. J.; PESCHON, J. J.; STOCKING, K. L.; FUJITA, T.; RAMASAMY, R.; CONNOLLY, E. S.; HUANG, J.; KISS, S.; ZHANG, Y.; CHOUDHRI, T. F.; MCTAGGART, R. A.; LIAO, H.; DROSPOULOS, J. H. F.; PRICE, V. L.; MARCUS, A. J. and MALISZEWSKI, C. R. (2002): Elucidation of the thromboregulatory role of CD39/ ectoapyrase in the ischemic brain. J. Clin. Invest. 109: 1031-1040.
125. THOMPSON, L. F.; ELTZSCHIG, H. K.; IBLA, J. C.; VAN DE WIELE, C. J.; RESTA, R.; MOROTE-GARCILA, J. C. and COLGAN, S. P. (2004): Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405.
126. ZIMMERMANN, H. (2006): Nucleotide signaling in nervous system development. Pflugers Arch. Eur. J. Physiol. 452: 573-588.
127. MISHRA, S. K.; BRAUN, N.; SHUKLA, V.; FÜLLGRABE, M.; SCHOMERUS, C.; KORF, H.-W.; GACHET, C.; IKEHARA, Y.; SÉVIGNY, J.; ROBSON, S. C. and ZIMMERMANN, H. (2006): Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development. 133: 675-684.
128. MILOSEVIC, J.; BRANDT, A.; ROEMUSS, U.; ARNOLD, A.; WEGNER, F.; SCHWARZ, S. C.; STORCH, A.; ZIMMERMANN, H. and SCHWARZ, J. (2006): Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling. J. Neurochem. 99: 913-923.